# Intrauterine Misoprostol Versus Rectal Misoprostol in Reducing Blood Loss During Cesarean Section

> **NCT03723031** · PHASE2 · UNKNOWN · sponsor: **Cairo University** · enrollment: 98 (estimated)

## Conditions studied

- Hemorrhage, Postpartum

## Interventions

- **DRUG:** Misoprostol

## Key facts

- **NCT ID:** NCT03723031
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-15
- **Primary completion:** 2020-04-15
- **Final completion:** 2020-05-15
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2020-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03723031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03723031, "Intrauterine Misoprostol Versus Rectal Misoprostol in Reducing Blood Loss During Cesarean Section". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT03723031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*